Review
Published on 13 Jan 2026
HtrA2/Omi: potential therapeutic targets for neurodegenerative diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2026.1705666
- 627 views
29,525 Publications
volumes
Volume 17 - 2026
Original Research
Accepted on 12 Jan 2026
Hericenone C Exhibits Anti-Nociceptive Effects through RORα-Mediated Suppression of TLR4 Transcription
Frontiers in Pharmacology
- 253 views
Original Research
Accepted on 12 Jan 2026
Unraveling the Anti-Colorectal Cancer Mechanisms of Acanthopanax senticosus Polysaccharide: A Multi-omics Investigation into Gut Microbiota-Metabolism-Immunity Crosstalk
Frontiers in Pharmacology
- 183 views
Original Research
Accepted on 12 Jan 2026
Global knockout of VEGFB improves lipoprotein lipase activity leading to an improved lipid profile during diabetes
Frontiers in Pharmacology
- 181 views
Volume 16 - 2025
Original Research
Published on 13 Jan 2026
Antiviral activity of Hellenia speciosa (J. Koenig) S.R. Dutta rhizome metabolites against human adenovirus: insights from molecular docking and in vitro studies
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1687104
- 961 views
Original Research
Published on 13 Jan 2026
PTX-loaded, polysorbate 80-functionalized brain-targeting pullulan nanoparticles for drug delivery
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1666997
- 716 views
Original Research
Published on 13 Jan 2026
Exploratory analysis of non-linear clozapine dose-concentration relationship in real-life hospital database
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1735337
- 850 views
Original Research
Published on 13 Jan 2026
GPR88 promotes neurite outgrowth of sensory neurons via activation of Gi/o
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1730247
- 880 views
Original Research
Published on 13 Jan 2026
Comparative efficacy and safety of mesalazine-based regimens with traditional Chinese medicines in mild-to-moderate ulcerative colitis
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1691460
- 884 views
Review
Published on 13 Jan 2026
Pain in polycystic ovary syndrome: a comprehensive bedside to bench perspective on an underrecognized symptom
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1670766
- 1,440 views
Original Research
Published on 13 Jan 2026
Real-world adverse event profile and signal characteristics of bevacizumab in glioma: a FAERS-based disproportionality analysis
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1705451
- 694 views
Editorial
Published on 13 Jan 2026
Editorial: Nutrition as a pharmacological approach to metabolic disorders and ageing
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1770988
- 787 views
Original Research
Published on 13 Jan 2026
Dulaglutide and pregnancy: a comprehensive safety assessment using the ex vivo placenta perfusion and in vitro models
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1765815
- 799 views
Review
Published on 13 Jan 2026
Vulnerable plaques in atherosclerosis: focus on angiogenesis-associated phenotypic crosstalk
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1737140
- 855 views
Original Research
Published on 13 Jan 2026
Clusterin protects against HFpEF by inhibiting UCHL1-mediated NLRP3 deubiquitylation and inflammasome activation
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1704023
- 784 views
Original Research
Published on 12 Jan 2026
Risk prediction model for severe potential drug-drug interactions in colorectal cancer patients: a real-world data study
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1714838
- 515 views
Review
Published on 12 Jan 2026
Combining exercise and nanoparticle-based therapies: a review of physiological synergies and pharmacological potential
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1679552
- 998 views
Original Research
Published on 12 Jan 2026
Insulin restores renal neprilysin (NEP) and attenuates the shedding of urinary NEP and KIM-1 in diabetic Akita mice
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1679651
- 779 views
Original Research
Published on 12 Jan 2026
Recombinant human thrombopoietin as a novel platelet-driven regulator accelerating hepatic regeneration in acute liver failure
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1701928
- 700 views
Original Research
Published on 12 Jan 2026
Real-world safety profile and mechanistic insights into regorafenib-induced liver failure: a pharmacovigilance study integrated with network toxicology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1698511
- 796 views
Systematic Review
Published on 12 Jan 2026
Preclinical evidence of ginkgo biloba extract on diabetic nephropathy: a systematic review and meta-analysis
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1717777
- 880 views
Systematic Review
Published on 12 Jan 2026
Risk of neutropenia associated with Sacituzumab govitecan: a systematic review combined with the FAERS database and meta-analysis
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1714638
- 1,069 views
Review
Published on 12 Jan 2026
Targeting CD73 and correcting adenosinergic signaling in critically ill patients
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1601481
- 979 views
Mini Review
Published on 12 Jan 2026
Aloe-emodin: from pharmacological mechanisms to clinical applications and future perspectives
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1741679
- 808 views